Dr. Stephen Hahn Nominated to Head FDA
Hahn is chief medical executive of The University of Texas MD Anderson Cancer Center in Houston
Seriously Ill Medicare Beneficiaries Face Financial Hardship
Majority of respondents rely on help from family and friends, at considerable cost
Intensive BP Control in Elderly With HTN May Aid Brain Health
Authors say benefit in functional outcomes might be seen with longer follow-up
Equivalence Seen Between Drug Classes for HTN Monotherapy
Thiazide, thiazide-like diuretics superior to ACEi; nondihydropyridine calcium channel blockers inferior
Borderline Personality Disorder May Raise Cardiometabolic Risk
Borderline personality traits, depression associated with extent of midlife cardiometabolic risk
October 2019 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for October 2019. This roundup includes the latest...
Recommendations Developed to Address Clinician Burnout
Six goals include creation of positive work and learning environments that prevent, reduce burnout
Rate of Surgical Bailout Low for TAVR
Outcomes poor when unplanned conversion to open heart surgery needed during TAVR
Small Drop in Calories Purchased With Labeling in Restaurants
Calories per transaction decreased slightly, but reduction decreased in year after implementation
AI Model Helps ID Those at Risk for Familial Hypercholesterolemia
Model may identify more who are at risk while substantially reducing the number of people screened
